Immunocore Plc
(NASDAQ) IMCR
Immunocore Plc Financials at a Glance
Market Cap
$1.55B
Revenue (TTM)
$372.97M
Net Income (TTM)
$26.77M
EPS (TTM)
$-0.71
P/E Ratio
-43.06
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$29.40
Volume
14,613
Open
$30.71
Price
$29.40
Volume
14,613
Open
$30.71
Previous Close
$29.40
Daily Range
$29.35 - $30.72
52-Week Range
$23.15 - $40.71
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$29.40
Volume
14,613
Open
$30.71
Previous Close
$29.40
Daily Range
$29.35 - $30.72
52-Week Range
$23.15 - $40.71
IMCR News
IMCR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Immunocore Plc
Industry
Biotechnology
Sector
Health CareEmployees
524
CEO
Bahija Jallal, PhD
Website
immunocore.comHeadquarters
Abingdon, OX14 4RY, GB
IMCR Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
-11%
Net Income Margin
-7%
Return on Equity
-10%
Return on Capital
-5%
Return on Assets
-3%
Earnings Yield
-2.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.55B
Shares Outstanding
50.69M
Volume
14.61K
Short Interest
0.00%
Avg. Volume
424.66K
Financials (TTM)
Gross Profit
$291.36M
Operating Income
$33.74M
EBITDA
$387.18K
Operating Cash Flow
$7.97M
Capital Expenditure
$3.23M
Free Cash Flow
$11.20M
Cash & ST Invst.
$864.15M
Total Debt
$43.56M
Immunocore Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$77.43M
-7.9%
Gross Profit
$74.81M
-10.6%
Gross Margin
96.61%
N/A
Market Cap
$1.55B
N/A
Market Cap/Employee
$3.14M
N/A
Employees
493
N/A
Net Income
$22.28M
+6.3%
EBITDA
$8.03M
+47.4%
Quarterly Fundamentals
Net Cash
$820.59M
+111.7%
Accounts Receivable
$73.98M
-11.0%
Inventory
$6.74M
+23.8%
Long Term Debt
$41.56M
-90.4%
Short Term Debt
$2.01M
+29.7%
Return on Assets
-2.51%
N/A
Return on Invested Capital
-4.91%
N/A
Free Cash Flow
$35.53M
-102.7%
Operating Cash Flow
$32.66M
-134.1%